Katalog Plus
Bibliothek der Frankfurt UAS
Bald neuer Katalog: sichern Sie sich schon vorab Ihre persönlichen Merklisten im Nutzerkonto: Anleitung.
Dieses Ergebnis aus BASE kann Gästen nicht angezeigt werden.  Login für vollen Zugriff.

Progress of Immune‐Inducible Biomaterials for Post‐Ablation Cancers

Title: Progress of Immune‐Inducible Biomaterials for Post‐Ablation Cancers
Authors: Zhao, Shuangshuang; Zhang, Zheng; Wu, Xincai; Chen, Yanwei; Li, Wenjun; Bao, Jiayan; Zhang, Xin; Chen, Baoding
Contributors: National Natural Science Foundation of China
Source: Advanced Healthcare Materials ; volume 14, issue 21 ; ISSN 2192-2640 2192-2659
Publisher Information: Wiley
Publication Year: 2025
Collection: Wiley Online Library (Open Access Articles via Crossref)
Description: Locoregional ablation therapies have considerable potential in eradicating cancers by killing tumor cells directly with different mechanisms, inducing immunogenic cell death, and subsequently forming the “in situ vaccine”. Nevertheless, a short period of immune time post‐ablation and rapidly reversed to an immunosuppressed state, may lead to a higher chance of tumor recurrence and metastasis. Therefore, boosting the efficacy of immunity and/or prolonging the duration of organismal immunity seem to be the key to suppressing tumor progression after minimally invasive ablation therapies. Currently, a number of nanoplatforms for post‐ablation immunotherapy are developed to address this challenge, including amplifying antitumor immunostimulatory signals, modulating immunosuppressive microenvironment, and improving antitumor immune responses. These approaches portend great promise for applications to improve local control and prevent tumor recurrence and distant metastasis. This review provides a concise overview of recent advances in immune‐inducible biomaterials for enhancing post‐ablation antitumor immunity, as well as strategies for their application in targeted drug delivery and sustained release to potentiate immune responses. Furthermore, main obstacles and potential breakthroughs for future development are discussed and prospected, providing insights to drive further innovation in immune‐inducible biomaterials for post‐ablation cancers.
Document Type: article in journal/newspaper
Language: English
DOI: 10.1002/adhm.202500785
Availability: https://doi.org/10.1002/adhm.202500785; https://advanced.onlinelibrary.wiley.com/doi/pdf/10.1002/adhm.202500785
Rights: http://creativecommons.org/licenses/by-nc-nd/4.0/
Accession Number: edsbas.DF71D49D
Database: BASE